Tilray Inc (NASDAQ:TLRY) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC cut its stake in Tilray Inc (NASDAQ:TLRY) by 33.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,713 shares of the company’s stock after selling 29,793 shares during the period. SG Americas Securities LLC’s holdings in Tilray were worth $78,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in TLRY. Ferguson Wellman Capital Management Inc. acquired a new stake in shares of Tilray during the third quarter worth $26,000. Ameritas Advisory Services LLC acquired a new stake in shares of Tilray during the fourth quarter worth $32,000. International Assets Investment Management LLC raised its holdings in shares of Tilray by 335.3% during the third quarter. International Assets Investment Management LLC now owns 23,639 shares of the company’s stock worth $42,000 after purchasing an additional 18,208 shares during the period. Vista Capital Partners Inc. acquired a new stake in shares of Tilray during the third quarter worth $42,000. Finally, Capital Management Associates Inc acquired a new stake in shares of Tilray during the third quarter worth $45,000. 9.35% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group increased their target price on shares of Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $2.70.

Tilray Stock Down 0.6 %

TLRY stock opened at $0.94 on Friday. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. Tilray Inc has a fifty-two week low of $0.91 and a fifty-two week high of $2.97. The firm’s 50-day simple moving average is $1.22 and its 200 day simple moving average is $1.51. The stock has a market cap of $884.49 million, a PE ratio of -3.14 and a beta of 2.07.

Tilray (NASDAQ:TLRY) last announced its earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). The company had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company’s revenue was up 8.7% on a year-over-year basis. As a group, sell-side analysts predict that Tilray Inc will post -0.2 EPS for the current year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.